Empagliflozin for acute myocardial infarction with increased risk of heart failure = fewer HF hospitalizations, no effect on mortality (EMPACT-MI)
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.